This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
Conference
New Research About Lung Cancer in People Who Have Never Smoked Creates Avenues for Personalized Treatment
September 21, 2021
The genomic landscape of lung cancer in individuals who have never smoked has not been well defined. New research indicates that most of these tumors may occur as a result of natural processes within the body. In addition, 3 distinct subtypes of tumors were identified, which could have important treatment implications. The findings are available in Nature Genetics: Genomic and evolutionary classification of lung cancer in never smokers. The research, the Sherlock-Lung study, sponsored by the National Cancer Institute (NCI), is managed under a support service contract between Westat and the NCI Integrative Tumor Epidemiology Branch (ITEB). Westat’s Jennifer Rosenbaum, M.P.H., is the Sherlock-Lung study manager and a coauthor of the article; Sara Glashofer, M.S., is the project director of the ITEB support services contract.
Learn more on how Westat is supporting research by searching for causes of lung cancer in never-smokers with the Sherlock-Lung study | Westat